THYMOGLOBULINE INDUCTION THERAPY CREATES EXCELLENT LONG-TERM OUTCOME OF PATIENTS WITH POSITIVE LYMPHOCYTE CROSSMATCH AFTER CARDIAC TRANSPLANTATION